Martin Knoz

Martin Knoz

Auto-generated profile, based on publicly available information

Martin Knoz

University Hospital Brno

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
Lucy VojtovaLucy Vojtova
Lucy Vojtova
VPVeronika Pavliňáková
Veronika Pavliňáková
JMJohana Muchová
Johana Muchová
KKKatarína Kacvinská
Katarína Kacvinská
JBJana Brtníková
Jana Brtníková
EFEva Filová
Eva Filová
Wound healing is a process regulated by a complex interaction of multiple growth factors including fibroblast growth factor 2 (FGF2). Although FGF2 appears in several tissue engineered studies, its applications are limited due to its low stability both in vitro and in vivo. Here, this shortcoming is overcome by a unique nine-point mutant of the low molecular weight isoform FGF2 retaining full biological activity even after twenty days at 37 °C. Crosslinked freeze-dried 3D porous collagen/chitosan scaffolds enriched with this hyper stable recombinant human protein named FGF2-STAB® were tested for in vitro biocompatibility and cytotoxicity using murine 3T3-A31 fibroblasts, for angiogenic potential using an ex ovo chick chorioallantoic membrane assay and for wound healing in vivo with 3-month old white New Zealand rabbits. Metabolic activity assays indicated the positive effect of FGF2-STAB® already at very low concentrations (0.01 µg/mL). The angiogenic properties examined ex ovo showed enhanced vascularization of the tested scaffolds. Histological evaluation and gene expression analysis by RT-qPCR proved newly formed granulation tissue at the place of a previous skin defect without significant inflammation infiltration in vivo. This work highlights the safety and biocompatibility of newly developed crosslinked collagen/chitosan scaffolds involving FGF2-STAB® protein. Moreover, these sponges could be used as scaffolds for growing cells for dermis replacement, where neovascularization is a crucial parameter for successful skin regeneration.

23 January 2024 in International Journal of Surgery
Verified
Journal Article
Open access
MKMartin Knoz
Martin Knoz
YWYu-Ming Wang
Yu-Ming Wang
Sheng-Dean LuoSheng-Dean Luo
Sheng-Dean Luo
Shao-Chun WuShao-Chun Wu
Shao-Chun Wu
WLWei-Che Lin
Wei-Che Lin
Johnson Chia-Shen YangJohnson Chia-Shen Yang
Johnson Chia-Shen Yang
Background: Contraction-type lymphatic vessels (LV) are considered suboptimal for lymphaticovenous anastomosis (LVA). However, despite these pathological changes, their functionality and link to outcomes have not been fully elucidated. The aim of this study was to determine the impact on outcomes when contraction-type LVs were used for LVA compared to the noncontraction-type (normal + ectatic) counterpart for treating lower limb lymphedema. Study design: Eighty-three patients with gynecologic cancer-related unilateral lower-limb lymphedema who underwent LVA as their primary treatment were enrolled in this study. The study group included 20 patients who used only contraction-type LVs. An additional 63 patients (control group) received noncontraction-type LVs only. Patients with a history of LVA, liposuction, or excisional therapy were excluded. Patient characteristics, intraoperative findings, functional parameters, and pre-LVA and post-LVA volume changes were recorded and matched using propensity scores. The primary endpoint was the volume change at 6/12 months after LVA. Results: After matching, 20 patients were included in each group. All parameters were matched, except that the study group still had a significantly inferior indocyanine green (ICG)-positive ratio, lymph flow-positive ratio, and washout-positive ratios (P<0.001, P=0.003, and P<0.001, respectively) when compared to the control group after matching. However, at 1-year follow-up, the postoperative percentage volume reduction was comparable between the groups (P=0.619). Conclusion: The use of contraction-type LVs for LVA is encouraged when no other LVs are available.

9 November 2022 in Burns
Verified
Journal Article
Closed access
JHJ. Holoubek
J. Holoubek
BLB. Lipový
B. Lipový
MKM. Knoz
M. Knoz
TKT. Kempný
T. Kempný
RCR. Chaloupková
R. Chaloupková
LVL. Vojtová
L. Vojtová

23 August 2022 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
TKTomas Kempny
Tomas Kempny
ZMZuzana Musilova
Zuzana Musilova
MKMartin Knoz
Martin Knoz
MJMarek Joukal
Marek Joukal
LBLipový Břetislav
Lipový Břetislav
HCHsutang Cheng
Hsutang Cheng

16 November 2023 in Biologia
Verified
Journal Article
Closed access
PDF file
PMPeter Makovický
Peter Makovický
EJEdita Jeklová
Edita Jeklová
BLBřetislav Lipový
Břetislav Lipový
FRFilip Raška
Filip Raška
MKMartin Knoz
Martin Knoz
LJLubomir Janda
Lubomir Janda

15 May 2021 in Acta Chirurgiae Plasticae
Verified
Journal Article
Closed access
ZDZ Dvořák
Z Dvořák
ACA Cheimaris
A Cheimaris
MKM Knoz
M Knoz
RPR Pink
R Pink
Nasal basal cell carcinomas are the most common malignant tumors of the facial skin, which predilectively affect areas exposed to sunlight, including the nasal area. After their radical removal, there is a variable complex defect of the affected area (defect of all 3 layers of the nose) or even a co …